Provided by Tiger Trade Technology Pte. Ltd.

Weight Loss Drugs

1,561.28
-8.4900-0.54%
Number of Gainers:- -
Number of Losers:7
Number of Flat:- -
PE:- -
High:1,579.75
Open:1,579.75
Low:1,559.99
Close:1,569.77
Volume:45.89M
Turnover:4.76B
Market Cap:1.63T
Float Cap:1.56T

Loading ...

Pfizer Steps Up in Obesity Race With New Phase 3 Berobenatide Trial in Japan

TIPRANKS
·
Sep 05

Novo Nordisk Advances New Obesity Drug NNC0721-8060 Into First Human Trial

TIPRANKS
·
Sep 05

Lilly Targets Type 1 Diabetes With New Tirzepatide Study: What Investors Should Watch

TIPRANKS
·
Sep 05

Pfizer’s Tilrekimig Eczema Trial: A Fresh Phase 3 Catalyst for PFE Investors

TIPRANKS
·
Sep 05

Pfizer’s Migraine Tablet Study Wraps Up, Supporting Pipeline Flexibility for PFE Investors

TIPRANKS
·
Sep 05

Novo Nordisk A/S Series B Stock Falls Friday, Underperforms Market

Dow Jones
·
Sep 05

Sector Update: Healthcare

MT Newswires Live
·
Sep 04

Novo Nordisk Foundation to Set Up Quantum Chip Facility

MT Newswires Live
·
Sep 04

Eli Lilly Stock (LLY) Gets a Bullish Note from JPMorgan Chase

TIPRANKS
·
Sep 04

Healthcare Stocks Pick up Steam as Investors Play Offense and Defense

Dow Jones
·
Sep 04

Pfizer Announces Q3 2026 Dividend of R$ 0.37 Per Unit for Brpfizbdr 006

Reuters
·
Sep 03

Medicus Pharma Shares Down 20.5% Premarket; Co, Pfizer Enter Licensing Deal for Experimental Cancer Therapy

THOMSON REUTERS
·
Sep 03

Aspen Sees Mounjaro Africa Sales Above $124 Million in 2027

Reuters
·
Sep 03

Political and General News Events from September 3

Reuters
·
Sep 03

Medicus Pharma Surges on Pfizer Licensing Deal for Experimental Cancer Therapy

Reuters
·
Sep 03

Medicus Pharma Signs Co-Development, Licensing Deal with Pfizer for Cd228v Antibody-Drug Conjugate

Reuters
·
Sep 03

Medicus Pharma - Pays Pfizer $12 Mln Upfront, $15 Mln Due on First Anniversary - SEC Filing

THOMSON REUTERS
·
Sep 03

Medicus Pharma - Pfizer Paid the Company a One-Time, Non-Refundable Payment of $2.0 Million

THOMSON REUTERS
·
Sep 03

Medicus Pharma - Enters Co-Development and License Agreement with Pfizer on Sept 2, 2026 - SEC Filing

THOMSON REUTERS
·
Sep 03

Structure Therapeutics Management Joins Three September Healthcare Investor Conferences

Reuters
·
Sep 03